Home » Topics » Regulatory

Regulatory
RSS

Antibacterial compositions for MRSA

Sep. 20, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

New treatment for diabetic keratopathy

Sep. 13, 1996

Mitsui Toatsu claims long-acting oral form of MS-551

Sep. 13, 1996

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Lilly reports new treatment for attention deficit/hyperactivity disorder

Sep. 13, 1996

Rhodanines for multiple sclerosis

Sep. 13, 1996

New formulation of selegiline

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.